Michel MS - Search Results

1

Cellular uptake and ex vivo urothelial penetration by oligodeoxynucleotides for optimizing treatment of transitional cell carcinoma.

Bolenz C, Trojan L, Gabriel U, Honeck P, Wendt-Nordahl G, Schaaf A, Alken P, Michel MS. Bolenz C, et al. Among authors: michel ms. Anal Quant Cytol Histol. 2008 Oct;30(5):265-73. Anal Quant Cytol Histol. 2008. PMID: 18980158

2

High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature.

Köhrmann KU, Michel MS, Gaa J, Marlinghaus E, Alken P. Köhrmann KU, et al. Among authors: michel ms. J Urol. 2002 Jun;167(6):2397-403. J Urol. 2002. PMID: 11992045 Review.

3

Evaluation of superficial papillary ablation by endoscopic lasers in an ex vivo kidney model.

Knoll T, Michel MS, Cueva-Martínez A, Spahn M, Bross S, Alken P, Köhrmann KU. Knoll T, et al. Among authors: michel ms. J Endourol. 2002 Apr;16(3):195-200. doi: 10.1089/089277902753716197. J Endourol. 2002. PMID: 12028632

4

Comparative investigations on the retrieval capabilities of various baskets and graspers in four ex vivo models.

Ptashnyk T, Cueva-Martinez A, Michel MS, Alken P, Köhrmann KU. Ptashnyk T, et al. Among authors: michel ms. Eur Urol. 2002 Apr;41(4):406-10. doi: 10.1016/s0302-2838(02)00063-5. Eur Urol. 2002. PMID: 12074812

5

Flexible ureterorenoscopy for the treatment of lower pole calyx stones: influence of different lithotripsy probes and stone extraction tools on scope deflection and irrigation flow.

Michel MS, Knoll T, Ptaschnyk T, Köhrmann KU, Alken P. Michel MS, et al. Eur Urol. 2002 Mar;41(3):312-6; discussion 316-7. doi: 10.1016/s0302-2838(02)00052-0. Eur Urol. 2002. PMID: 12180234

6

Objective and subjective changes in patients with Peyronie's disease after management with shockwave therapy.

Michel MS, Ptaschnyk T, Musial A, Braun P, Lenz ST, Alken P, Köhrmann KU. Michel MS, et al. J Endourol. 2003 Feb;17(1):41-4; discussion 44. doi: 10.1089/089277903321196788. J Endourol. 2003. PMID: 12639361

7

Intrinsic presence of poly (ADP-ribose) is significantly increased in malignant prostate compared to benign prostate cell lines.

McNealy T, Frey M, Trojan L, Knoll T, Alken P, Michel MS. McNealy T, et al. Among authors: michel ms. Anticancer Res. 2003 Mar-Apr;23(2B):1473-8. Anticancer Res. 2003. PMID: 12820412

8

Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.

Liao Y, Grobholz R, Abel U, Trojan L, Michel MS, Angel P, Mayer D. Liao Y, et al. Among authors: michel ms. Int J Cancer. 2003 Nov 20;107(4):676-80. doi: 10.1002/ijc.11471. Int J Cancer. 2003. PMID: 14520710

9

Measurement of renal anatomy for prediction of lower-pole caliceal stone clearance: reproducibility of different parameters.

Knoll T, Musial A, Trojan L, Ptashnyk T, Michel MS, Alken P, Köhrmann KU. Knoll T, et al. Among authors: michel ms. J Endourol. 2003 Sep;17(7):447-51. doi: 10.1089/089277903769013577. J Endourol. 2003. PMID: 14565873

10

Micelle delivery of doxorubicin increases cytotoxicity to prostate carcinoma cells.

McNealy TL, Trojan L, Knoll T, Alken P, Michel MS. McNealy TL, et al. Among authors: michel ms. Urol Res. 2004 Aug;32(4):255-60. doi: 10.1007/s00240-003-0321-6. Epub 2004 Jan 9. Urol Res. 2004. PMID: 14714155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters